Controversies in thyroid-related orbitopathy: Radiation and decompression

International Ophthalmology Clinics

Volumn 45, Issue 4, 2005, Pages 1-14

  Hatten, Mark P ^a   Rubin, Peter A D ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; PLACEBO; PREDNISONE; THYROTROPIN RECEPTOR;

CATARACT; CLINICAL FEATURE; DECOMPRESSION SURGERY; DIPLOPIA; ENDOCRINE OPHTHALMOPATHY; EXOPHTHALMOS; EYE DISEASE; EYE SURGERY; GRAVES DISEASE; HUMAN; OPTIC NERVE DISEASE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RETINOPATHY; REVIEW; SIDE EFFECT; STEROID THERAPY; THYROID DISEASE; TREATMENT INDICATION; TREATMENT OUTCOME; X IRRADIATION;

COMBINED MODALITY THERAPY; DECOMPRESSION, SURGICAL; GLUCOCORTICOIDS; GRAVES OPHTHALMOPATHY; HUMANS; OPHTHALMOLOGIC SURGICAL PROCEDURES;

EID: 27544471812     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.iio.0000178236.82540.81     Document Type: Review

References (90)

1. Jacobson DL, Gange SJ, Rose NR, et al. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol. 1997;84:223-243.
2. Hatton MP, Rubin PAD. The pathophysiology of thyroid-related ophthalmopathy. Ophthalmol Clin North Am. 2002;15:113-119.
3. Bahn RS, Heufelder AE. Pathogenesis of Graves' ophthalmopathy. N Engl J Med. 1993; 329:1468-1475.
4. Kazim M, Goldberg RA, Smith TJ. Insights into the pathogenesis of thyroid-related orbitopathy. Arch Ophthalmol. 2002;120:380-386.
5. Donaldson SS, Bagshaw MA, Kriss JP. Supervoltage orbital radiotherapy for Graves' ophthalmopathy. J Clin Endocrinol Metab. 1983;37:276-285.
6. Werner SC. Modification of the classification of the eye changes of Graves' disease: recommendations of the Ad Hoc Committee of the American Thyroid Association. J Clin Endomnol Metab. 1977;44:203-204.
7. Werner SC. Modification of the classification of the eye changes of Graves' disease. Am J Ophthalmol. 1977;83:725-727.
8. Van Dyk HJL. Orbital Graves' disease: a modification of the "NOSPECS" classification. Ophthalmology. 1981;88:479-483.
9. Mourits M, Koorneef L, Wiersinga WM, et al. Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach. Br J Ophthalmol. 1989;73: 639-644.
10. Prummel MF, Mourits MP, Berghout A, et al. Prednisone and cyclosporine in the treatment of severe Graves' ophthalmopathy. N Engl J Med. 1989;321:1353-1359.
11. Gorman CA. The measurement of change in Grave's ophthalmopathy. Thyroid. 1998;8: 539-543.
12. Gorman CA. Clever is not enough: NOSPECS is form in search of function. Thyroid. 1991;1:3S3-355.
13. Bartalena L, Marcocci C, Bogazzi F. A new ophthalmology index for quantitation of eye changes of Graves' disease. Acta Endocrinol. 1989;121(Suppl 2):190-192.
14. Bahn RS, Garrity JA, Bartley GB, et al. Diagnostic evaluation of Graves' ophthalmopathy. Endocrinol Metab Clin North Am. 1988;17:527-545.
15. Feldon SE. Radiation therapy for Graves' ophthalmopathy: trick or treat? Ophthalmology. 2001;108:1521-1522.
16. Bartley GB. Evolution of classification systems for Graves' ophthalmopathy. Ophthalmic Plast Reconstr Surg. 1995;11:229-237.
17. Bartley GB, Gorman CA. The Mayo orbital radiotherapy for Grave's ophthalmology (ORGO) study: lessons learned. Ophthalmic Plast Reconstr Surg. 2002;18:170-172.
18. Juler FA. Diseases of the orbit. Acute purulent keratitis in exophthalmos goiter treated by repeated tarsorrhaphy, resection of cervical sympathetic and x-rays: retention of vision in one eye. Trans Ophthalmol Soc UK. 1913;33:58-62.
19. Thomas HM, Woods AC. Progressive exophthalmos following thyroidectomy. Bull Johns Hopkins Hosp. 1936;59:99-113.
20. Beierwaltes WH. Irradiation of the pituitary in the treatment of malignant exophthalmos. J Clin Endocrinol. 1951;11:512-530.
21. Rodemann HP, Bamberg M. Cellular basis of radiation-induced fibrosis. Radiother Oncol. 1995;35:83-90.
22. Leer JWH, van Houtte P, Davelaar J. Indications and treatment schedules for irradiation of benign diseases: a survey. Radiother Oncol. 1998;48:249-257.
23. Van Ruyven RLJ, van den Bosch WA, Mulder PGH, et al. The effect of retrobulbar irradiation on exophthalmos, ductions, and soft tissue sign in Graves' ophthalmopathy: a retrospective analysis of 90 cases. Eye. 2000;14:761-764.
24. Sandier HM, Rubenstein JH, Fowble BL, et al. Results of radiotherapy for thyroid ophthalmopathy. Int J Radiat Oncol Biol Phys. 1989;17:823-827.
25. Wiersinga WM, Smit T, Schuster-Uittenhoeve ALJ, et al. Therapeutic outcome of prednisone medication and of orbital irradiation in patients with Graves' ophthalmopathy. Ophthalmologica. 1988;197:75-84.
26. Brennan MW, Leone CR, Janaki L. Radiation therapy for Graves' disease. Am J Ophthalmol 1983;96:195-199.
27. Bartalena L, Marcocci C, Tanda ML, et al. Orbital radiotherapy for Graves' ophthalmopathy. Thyroid. 2002;12:245-250.
28. Kao SCS, Kendler DL, Nugent RA, et al. Radiotherapy in the management of thyroid orbitopathy: computed tomography and clinical outcomes. Arch Ophthalmol. 1993;111: 819-823.
29. Petersen IA, Kriss JP, McDougal IR, et al. Prognostic factors in the radiotherapy of Graves' ophthalmopathy. Int J Radiat Oncol Biol Phys. 1990;19:259-264.
30. Marcocci C. Usefulness of orbital radiotherapy for Graves' ophthalmopathy: evidence in favor. J Endocrinol Invest. 2003;26:7-9.
31. Leone CR, Piest KL, Newman RJ. Medial and lateral wall decompression for thyroid ophthalmopathy. Am J Ophthalmol. 1989;108:160-166.
32. Mounts MP, van Kempen-Harteveld ML, Garcia MBG, et al. Radiotherapy for Graves' orbitopathy: randomized placebo-controlled study. Lancet. 2000;355:1505-1509.
33. Gorman CA, Garrity JA, Fatourechi V, et al. A prospective, randomized, double-blind, placebo-controlled study of orbital radiotherapy for Graves' ophthalmopathy. Ophthalmology. 2001;108:1523-1534.
34. Gorman CA, Garrity JA, Fatourechi V, et al. The aftermath of orbital radiotherapy for Graves' ophthalmopathy. Ophthalmology. 2002;109:2100-2107.
35. Kazim M. Radiotherapy for Graves' orbitopathy: the Columbia University Experience. Ophthalmic Plast Reconstr Surg. 2002;18:173-174.
36. Ainbinder DJ, Halligan JB. Letter to the editor. Ophthalmology. 2003;110:449.
37. Meyer DR. Letter to the editor. Ophthalmology. 2003;110:450-451.
38. Steinsaper KD, Goldberg RA. Letter to the editor. Ophthalmology. 2003;110:452.
39. Bartalena L. Letter to the editor. Ophthalmology. 2002;110:452-453.
40. Jones A. Orbital x-ray therapy of progressive exophthalmos. Br J Radiol. 1951;288: 637-646.
41. Beierwaltes WH. X-ray treatment of malignant exophthalmos: a report on 28 patients. J Clin Endomnol Metab. 1953;13:1090-1100.
42. Brown J, Coburn JW, Wigod RA, et al. Adrenal steroid therapy of severe infiltrative ophthalmopathy of Graves' disease. Am J Med. 1963;34:786-795.
43. Bartalena L, Pinchera A, Marcocci C. Management of Graves' ophthalmopathy: reality and perspectives. Endocr Rev. 2000;21:168-199.
44. Prummel MF, Mounts MP, Blank L, et al. Randomised double-blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy. Lancet. 1993;342:949-954.
45. Kazim M, Trokel S, Moore S. Treatment of acute Graves' orbitopathy. Ophthalmology. 1991;98:1443-1448.
46. Marcocci C, Bartalena L, Tanda ML, et al. Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study. J Clin Endomnol Metab. 2001;86:3562-3567.
47. Bartalena L, Marcocci C, Chiovato L, et al. Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: comparison with systemic corticosteroids alone. J Clin Endomnol Metab. 1983;56:1139-1144.
48. Kinyoun JL, Kalina RE, Brower SA, et al. Radiation retinopathy after orbital irradiation for Graves' ophthalmopathy. Arch Ophthalmol. 1984;102:1473-1476.
49. Parker RG, Withers HR. Radiation retinopathy. JAMA. 1988;259:43.
50. Robertson DM, Buettner H, Gorman CA, et al. Retinal microvascular abnormalities in patients treated with external radiation for Graves ophthalmopathy. Arch Ophthalmol. 2003;121:652-657.
51. Hahn CA, Halperin EC. External beam radiotherapy for thyroid eye disease. In: Dutton JJ, Haik BG, eds. Thyroid Eye Disease: Diagnosis and Treatment. New York: Marcel Decker; 2002:347-356.
52. Kahaly GJ, Rosler HP, Pitz S, et al. Low-versus high-dose radiotherapy for Graves' ophthalmopathy: a randomized, single blind trial. J Clin Endocrinol Metab. 2000;85:102-108.
53. Lyons CJ, Rootman J. Orbital decompression for disfiguring exophthalmos in thyroid orbitopathy. Ophthalmology. 1994;101:223-230.
54. Rubin PA, Watlins LM, Rumelt S, et al. Orbital computed tomographic characteristics of globe subluxation in thyroid orbitopathy. Ophthalmology. 1998;105:2061-2064.
55. Khan JA, Doane JF, Whitacre MM. Does decompression diminish the discomfort of severe dysthyroid orbitopathy. Ophthalmic Plast Reconstr Surg. 1995;11:109-112.
56. Goldberg RA, Hwang MM, Garbutt MV, et al. Orbital decompression for non-Graves' orbitopathy: a consideration of extended indications for decompression. Ophthalmic Plast Reconstr Surg. 1995;11:245-252.
57. Stabile JR, Trokel SM. Increase in orbital volume obtained by decompression in dried skulls. Am J Ophthalmol. 1983;95:327-331.
58. McCord CD. Current trends in orbital decompression. Ophthalmology. 1985;92:21-33.
59. Guyton JS. Decompression of the orbit. Surgery. 1946;19:790-809.
60. Wolfe SA. A rationale for the surgical treatment of exophthalmos and exorbitism. J Maxillofac Surg. 1977;5:249-257.
61. Wolfe SA, Hemmy D. How much does the lateral wall help in expanding the orbit? Ophthalmic Plast Reconstr Surg. 1988;4:111-114.
62. Goldberg RA, Kim AJ, Kerivan KM. The lacrimal keyhole, orbital door jamb, and basin of the inferior orbital fissure. Arch Ophthalmol. 1998;116:1618-1624.
63. Kikkawa DO, Pornpanich K, Cruz RC, et al. Graded orbital decompression based on severity of proptosis. Ophthalmology. 2002;109:1219-1224.
64. Peyster RG, Ginsberg F, Silber JH, et al. Exophthalmos caused by excessive fat: CT volumetric analysis and differential diagnosis. AJNR Am J Neuroradiol. 1986;146:459-464.
65. Forbes G, Gorman CA, Gehring D, et al. Computer analysis of orbital fat and muscle volumes in Graves' ophthalmopathy. AJNR Am J Neuroradiol 1983;4:737-740.
66. Forbes G, Gorman CA, Brennan MD, et al. Ophthalmopathy of Graves' disease: computerized volume measurements of the orbital fat and muscle. AJNR Am J Neuroradiol. 1986;7:651-656.
67. Olivari N. Transpalpebral decompression of endocrine ophthalmopathy (Graves' disease) by removal of intraorbital fat: experience with 147 operations over 5 years. Plast Reconstr Surg. 1991;87:627-641.
68. Adenis JP, Robert PY, Lasudry JGH, et al. Treatment of proptosis with fat removal orbital decompression in Graves' ophthalmopathy. Eur J Ophthalmol. 1998;8:246-252.
69. Gockeln R, Winter R, Sistani F, et al. Minimal invasive decompression of the orbit in Graves' orbitopathy. Strabismus. 2000;8:251-259.
70. Unal M, Ileri F, Konuk O, et al. Balanced orbital decompression combined with fat removal in Graves' ophthalmopathy. Ophthalmic Plast Reconstr Surg. 2003;19:112-118.
71. Van der Wal KGH, de Visscher JGAM, Boukes RJ, et al. Surgical treatment of Graves orbitopathy: a modified balanced technique. Int J Oral Maxillofac Surg. 2001;30:254-258.
72. Kazim M, Trokel SL, Acaroglu G, et al. Reversal of dysthyroid optic neuropathy following orbital fat decompression. Br J Ophthalmol. 2000;84:600-605.
73. Garrity JA, Fatourechi V, Bergstralh EJ, et al. Results of transantral orbital decompression in 428 patients with severe Graves' ophthalmopathy. Am J Ophthalmol. 2003;116: 533-547.
74. Goldberg RA, Shorr N, Cohen MS. The medial orbital strut in the prevention of postdecompression dystopia in dysthyroid ophthalmopathy. Ophthalmic Plast Reconstr Surg. 1992;8:32-34.
75. Seiff SR, Tovilla JL, Carter SR, et al. Modified orbital decompression for dysthyroid orbitopathy. Ophthalmic Plast Reconstr Surg. 2000;16:62-66.
76. Metson R, Samaha M. Reduction of diplopia following endoscopic orbital decompression: the orbital sling technique. Laryngoscope. 2002;112:1753-1757.
77. Grahm SM, Brown CL, Carter KD, et al. Medial and lateral orbital wall surgery for balanced decompression in thyroid eye disease. Laryngoscope. 2003;113:1206-1209.
78. Kacker A, Kazim M, Murphy M, et al. "Balanced" orbital decompression for severe Graves' orbitopathy: technique with treatment algorithm. Otolaryngol Head Neck Surg. 2003;128:228-235.
79. Shepard KG, Levin PS, Terris DJ. Balanced orbital decompression for Graves' ophthalmopathy. Laryngoscope. 1998;108:1648-1653.
80. Goldberg RA. The evolving paradigm of orbital decompression surgery. Arch Ophthalmol. 1998;116:95-96.
81. Goldberg RA, Perry JD, Hortaleza V, et al. Strabismus after balanced medial plus lateral wall versus lateral wall only orbital decompression for dysthyroid orbitopathy. Ophthalmic Plast Reconstr Surg. 2000;16:271-277.
82. Nunery WR, Nunery CW, Martin RT, et al. The risk of diplopia following orbital floor and medial wall decompression in subtypes of ophthalmic Graves' disease. Ophthalmic Plast Reconstr Surg. 1997;13:153-160.
83. Shorr N, Neuhaus RW, Baylis HI. Ocular motility problems after orbital decompression for dysthyroid ophthalmopathy. Ophthalmology. 1982;89:323-328.
84. Trobe JD, Glaser JS, Laflamme P. Dysthyroid optic neuropathy: clinical profile and rationale for management. Arch Ophthalmol. 1978;96:1199-1209.
85. Chang EL, Bernardino CR, Rubin PAD. Transcaruncular orbital decompression for management of compressive optic neuropathy in thyroid-related orbitopathy. Plast Reconstr Surg. 2003;112:739-747.
86. Rush S, Winterkorn JMS, Rochelle Z. Objective evaluation of improvement in optic neuropathy following radiation therapy for thyroid eye disease. Int J Radiat Oncol Biol Phys. 2000;47:191-194.
87. Soares-Welch CV, Fatourechi V, Hartley GB, et al. Optic neuropathy of Graves' disease: results of transantral orbital decompression and long-term follow-up in 215 patients. Am J Ophthalmol. 2003;136:433-441.
88. Carter KD, Frueh BR, Hessburg TP, et al. Long-term efficacy of orbital decompression for compressive optic neuropathy of Graves' eye disease. Ophthalmology. 1991;98:1435-1442.
89. Hutcison BM, Kyle PM. Long-term visual outcome following orbital decompression for dysthyroid eye disease. Eye. 1995;9:578-581.
90. Drewry RD. Optic neuropathy in thyroid eye disease. In: Dutton JJ, Haik BG, eds. Thyroid Eye Disease: Diagnosis and Treatment. New York: Marcel Decker; 2002:327-334.